These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8333775)

  • 1. Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis.
    Greally P; Hussain MJ; Vergani D; Price JF
    Arch Dis Child; 1993 Jun; 68(6):785-7. PubMed ID: 8333775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.
    Greally P; Hussain MJ; Vergani D; Price JF
    Arch Dis Child; 1994 Jul; 71(1):35-9. PubMed ID: 8067791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer.
    Rosenecker J; Harms KH; Bertele RM; Pohl-Koppe A; v Mutius E; Adam D; Nicolai T
    Infection; 1996; 24(1):5-8. PubMed ID: 8852455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
    Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
    Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function.
    Seyfarth J; Sivagurunathan S; Ricken S; Weinreich G; Olbrich L; Taube C; Mayatepek E; Schramm D; Jacobsen M
    J Cyst Fibros; 2019 Jan; 18(1):71-77. PubMed ID: 30389600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity.
    Forsyth KD; Hohmann AW; Martin AJ; Bradley J
    Arch Dis Child; 1988 Aug; 63(8):953-7. PubMed ID: 3046514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of tumor necrosis factor and interleukin-1 in cystic fibrosis.
    Brown MA; Morgan WJ; Finley PR; Scuderi P
    Pediatr Pulmonol; 1991; 10(2):86-91. PubMed ID: 2030926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis.
    Briars GL; Dean TP; Murphy JL; Rolles CJ; Warner JO
    Arch Dis Child; 1995 Jul; 73(1):74-6. PubMed ID: 7639556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of IgG serum levels in cystic fibrosis].
    Vázquez Cordero C; Sánchez Obregón M; Molinuevo Alvaro J; Larrea Rementería F; Vitoria Cormenzana JC; Sojo Aguirre A
    An Esp Pediatr; 1988 Apr; 28(4):321-4. PubMed ID: 3400941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal inflammation in cystic fibrosis.
    Smyth RL; Croft NM; O'Hea U; Marshall TG; Ferguson A
    Arch Dis Child; 2000 May; 82(5):394-9. PubMed ID: 10799435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.
    Dagli E; Warner JA; Besley CR; Warner JO
    Arch Dis Child; 1992 Apr; 67(4):479-81. PubMed ID: 1580675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis.
    Greally P; Hussein MJ; Cook AJ; Sampson AP; Piper PJ; Price JF
    Arch Dis Child; 1993 Mar; 68(3):389-92. PubMed ID: 8385438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting energy expenditure and substrate oxidation rates in cystic fibrosis.
    Bowler IM; Green JH; Wolfe SP; Littlewood JM
    Arch Dis Child; 1993 Jun; 68(6):754-9. PubMed ID: 8333766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive smoking and impaired lung function in cystic fibrosis.
    Smyth A; O'Hea U; Williams G; Smyth R; Heaf D
    Arch Dis Child; 1994 Oct; 71(4):353-4. PubMed ID: 7979533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased binding of limulin to alpha 2-macroglobulin and immunoglobulin M from cystic fibrosis patients.
    Owens-Williams L; Shapira E
    J Pediatr Gastroenterol Nutr; 1982; 1(4):567-70. PubMed ID: 6193262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis in Asians.
    Bowler IM; Estlin EJ; Littlewood JM
    Arch Dis Child; 1993 Jan; 68(1):120-2. PubMed ID: 8434995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
    Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
    Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers--evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases.
    Hentschel J; Müller U; Doht F; Fischer N; Böer K; Sonnemann J; Hipler C; Hünniger K; Kurzai O; Markert UR; Mainz JG
    J Immunol Methods; 2014 Feb; 404():41-51. PubMed ID: 24370751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
    Sagel SD; Thompson V; Chmiel JF; Montgomery GS; Nasr SZ; Perkett E; Saavedra MT; Slovis B; Anthony MM; Emmett P; Heltshe SL
    Ann Am Thorac Soc; 2015 May; 12(5):708-17. PubMed ID: 25714657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.